» Articles » PMID: 33805912

Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling

Abstract

The high incidence of obesity is associated with an increasing risk of several chronic diseases such as cardiovascular disease, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Sustained obesity is characterized by a chronic and unsolved inflammation of adipose tissue, which leads to a greater expression of proinflammatory adipokines, excessive lipid storage and adipogenesis. The purpose of this review is to clarify how inflammatory mediators act during adipose tissue dysfunction in the development of insulin resistance and all obesity-associated diseases. In particular, we focused our attention on the role of inflammatory signaling in brown adipose tissue (BAT) thermogenic activity and the browning of white adipose tissue (WAT), which represent a relevant component of adipose alterations during obesity. Furthermore, we reported the most recent evidence in the literature on nutraceutical supplementation in the management of the adipose inflammatory state, and in particular on their potential effect on common inflammatory mediators and pathways, responsible for WAT and BAT dysfunction. Although further research is needed to demonstrate that targeting pro-inflammatory mediators improves adipose tissue dysfunction and activates thermogenesis in BAT and WAT browning during obesity, polyphenols supplementation could represent an innovative therapeutic strategy to prevent progression of obesity and obesity-related metabolic diseases.

Citing Articles

Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson's Disease.

Hemmati F, Valian N, Ahmadiani A, Mohamed Z, Azman Ali R, Mohamed Ibrahim N Iran J Pharm Res. 2025; 23(1):e144200.

PMID: 39830652 PMC: 11742580. DOI: 10.5812/ijpr-144200.


Thymoquinone: A comprehensive review of its potential role as a monotherapy for metabolic syndrome.

Ibrahim K, Hudu S, Jega A, Taha A, Yusuf A, Usman D Iran J Basic Med Sci. 2024; 27(10):1214-1227.

PMID: 39229585 PMC: 11366942. DOI: 10.22038/ijbms.2024.77203.16693.


Sweet triterpenoid glycoside from ameliorates obesity-induced insulin resistance through inhibiting the TLR4/NF-κB/NLRP3 inflammatory pathway.

Li J, He J, He H, Wang X, Zhang S, He Y Curr Res Food Sci. 2024; 8:100677.

PMID: 38303998 PMC: 10831159. DOI: 10.1016/j.crfs.2024.100677.


The Effect of an Innovative Combination of Bergamot Polyphenolic Fraction and L. Extract on Weight Gain Reduction and Fat Browning in Obese Mice.

Nucera S, Scarano F, Macri R, Mollace R, Gliozzi M, Carresi C Int J Mol Sci. 2024; 25(1).

PMID: 38203362 PMC: 10779365. DOI: 10.3390/ijms25010191.


Browning of Adipocytes: A Potential Therapeutic Approach to Obesity.

Schirinzi V, Poli C, Berteotti C, Leone A Nutrients. 2023; 15(9).

PMID: 37432449 PMC: 10181235. DOI: 10.3390/nu15092229.


References
1.
Birsoy K, Festuccia W, Laplante M . A comparative perspective on lipid storage in animals. J Cell Sci. 2013; 126(Pt 7):1541-52. DOI: 10.1242/jcs.104992. View

2.
Han M, Jung D, Morel C, Lakhani S, Kim J, Flavell R . JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science. 2012; 339(6116):218-22. PMC: 3835653. DOI: 10.1126/science.1227568. View

3.
Sharma R, Gescher A, Steward W . Curcumin: the story so far. Eur J Cancer. 2005; 41(13):1955-68. DOI: 10.1016/j.ejca.2005.05.009. View

4.
Hersoug L, Moller P, Loft S . Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity. Obes Rev. 2015; 17(4):297-312. DOI: 10.1111/obr.12370. View

5.
Ozcan U, Cao Q, Yilmaz E, Lee A, Iwakoshi N, Ozdelen E . Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004; 306(5695):457-61. DOI: 10.1126/science.1103160. View